Controlled registryRecord class / Research peptides Tesamorelin RECORD TESAMORELIN / CLASS RESEARCH PEPTIDES / IDENTIFIERS 4. AcuPep uses this page to preserve the product-to-SKU link before evidence requirements enter the inquiry queue.
GHRH(1-44) carrying a trans-3-hexenoyl group on the alpha-amine of Tyr1 and a C-terminal Leu44 amide · research-use-only peptide; the molecule is the active ingredient of FDA-approved prescription products and this material is not one of them
Control sequence Identifier lock precedes evidence applicability Resolve product, content and SKU; then declare quantity, destination, timing and acceptance questions.
Identifier matrix
Controlled content / SKU pairs 2 mg TSM2
5 mg TSM5
10 mg TSM10
20 mg TSM20
STATUS: catalog reference. Availability, presentation and commercial constraints require a returned quotation.
Evidence gate Declare the required record type and acceptance context. Evidence is linked only when it applies to the requested configuration or released lot.
Storage constraint Follow the released-lot COA and the supplier's instructions. This product's presentations carry their own conditions and they are deliberately not one number: the lyophilized vial and the dual-chamber powder/diluent cartridge are held at 2 to 8 degrees Celsius, protected from light and moisture, and the single-chamber liquid cartridge at 15 to 25 degrees Celsius, protected from light and not frozen. Those are handling policies per presentation, not stability claims. Both figures are read out of this catalogue's own governed presentation records - the lyophilized vial, the dual-chamber powder/diluent cartridge and the single-chamber liquid cartridge each carry their condition in the controlled source - and neither is taken from the approved products' labelling. No formulation, lyophilisation or reconstitution stability study for this molecule was retrieved this round — the targeted literature query returns eight records which on inspection are analytical-method and clinical papers, against a same-round control of 781 for a generic lyophilized-peptide stability query — so no evidence tier of any kind attaches to this material's handling, and every stability, in-use and excursion statement must rest on the lot's own study or on the configuration's own study. The approved finished products are stored at 20 to 25 degrees Celsius controlled room temperature; that figure belongs to the EGRIFTA SV and EGRIFTA WR labels, it describes sterile finished drug products, and it does not qualify this material.
Technical intake / linked record Reference Tesamorelin in a controlled brief Include SKU, content, quantity, destination and evidence requirements. AcuPep will preserve these identifiers in the inquiry record.
Was this page useful for your review? Yes Not yet